Trials / Conditions / CD20-positive Non-Hodgkin Lymphoma
CD20-positive Non-Hodgkin Lymphoma
3 registered clinical trials studyying CD20-positive Non-Hodgkin Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma NCT04853329 | Conjupro Biotherapeutics, Inc. | Phase 1 |
| Recruiting | Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma NCT06021678 | Guangzhou Excelmab Inc. | Phase 1 / Phase 2 |
| Terminated | Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL) NCT03578198 | Seoul National University Hospital | Phase 2 |